P3-13-06: Cardiovascular Magentic Resonance Imaging and Radiation-Induced Heart Disease Following Radiotherapy for Breast Cancer.

Abstract

Background: Radiotherapy (RT) forms a vital component of treatment for breast cancer, contributing to the increasing number of survivors worldwide. It is known from historical cohorts that breast RT increased the risk of developing heart disease 10 years or more following treatment. It is less certain whether the lower cardiac radiation doses received during modern RT still increase cardiac risk. Cardiovascular Magnetic Resonance (CMR) imaging has the potential to provide early surrogate markers of radiation-induced heart disease that may help predict which women will be at increased risk in the future. Methods: This is a prospective longitudinal imaging study to evaluate CMR findings in a cohort of women receiving adjuvant RT for early breast cancer at the Oxford Cancer Centre. The patients undergo CMR imaging (with gadolinium enhancement and adenosine stress), Doppler echocardiography, blood testing (including BNP and troponin), ECG and clinical examination prior to RT, within 72 hours of completing RT, and at 3 months, 6 months and 5 years following RT. The results of these investigations will be related to cardiac radiation exposure estimated using 3D-dosimetric data obtained by analysis of CT-based RT planning. Recruitment and Provisional Results: As of May 2011, 30 women have been recruited. The women had a mean age of 57.1 years (range = 42.0 to 63.9). All women had left-sided cancer and none received adjuvant cytotoxic chemotherapy. The mean whole heart dose was 1.47 Gray (range = 0.65 to 4.20), the mean left ventricle dose was 2.03 (range = 0.88 to 6.99) and the mean left coronary artery dose was 7.55 Gray (range = 1.50 to 24.59). Preliminary analysis of the first 10 participants showed that all had a normal left ventricular ejection fraction at baseline (mean 76%, range 60–82%) and immediately following RT (mean reduction 3%, p=0.18). None had myocardial oedema as detected by T2-STIR imaging or fibrosis and scarring as demonstrated by late gadolinium enhancement (LGE). Conclusion and Future Plans: Preliminary results suggest that the relatively low heart doses received by the women undergoing modern CT-planned left breast RT at the Oxford Cancer Centre do not result in any cardiovascular abnormality detectable by CMR imaging. Further and updated results will be available for the San Antonio Breast Cancer Symposium. Recruitment will continue until at least 20 women have completed baseline scans and follow-up scans up to 6 months. At this stage a full analysis will be performed including a wider range of CMR endpoints including: - Overall LV systolic function (EF and volumes) - Regional wall motion analysis - T2-weighted imaging (oedema) - T1 and T2 mapping (quantitative T1 and T2 relaxation times) - Tagged myocardial strain analysis - Stress perfusion defects (endothelial/microcapillary damage) - Late gadolinium (LGE) imaging (fibrosis/scarring) Depending on the results of this analysis, recruitment may be expanded to include women with either lower cardiac risk (e.g. with right-sided breast cancer) or higher cardiac risk (e.g. receiving anthracycline chemotherapy). Citation Information: Cancer Res 2011;71(24 Suppl):Abstract nr P3-13-06.

Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977–2005

“…More than thirty studies, including around a quarter of a million women irradiated for breast cancer during the past five decades, have reported heart disease rates in women irradiated for left-sided cancer compared with women irradiated for right-sided cancer [14] . In most of these studies, the left versus right cardiac event rate ratio was greater than one and, in studies where specific types of heart disease were examined, ischaemic heart disease was the type most commonly affected.…”

Automatic Coronary Artery Calcium Scoring on Radiotherapy Planning CT Scans of Breast Cancer Patients: Reproducibility and Association with Traditional Cardiovascular Risk Factors

“…Difference in respiratory motion artifacts between CT scans performed with and without breath-hold has very likely contributed to this lower reliability of automatic CAC scoring, since 237 out of 294 (81%) patients had one CT scan performed with breath-hold and one scan without. Around 50% of all breast cancer patients are treated with radiotherapy and therefore routinely undergo planning CT scans[32,33]. …”

Facile Nanolization Strategy for TherapeuticGanoderma Lucidum Spore Oilto Achieve Enhanced Protection against Radiation‐Induced Heart Disease

“…Nevertheless, RT happens to incompletely eliminate tumor cells accompanied by inevitable hazards to surrounding normal tissues in practical for its unsatisfactory selectivity . Among which, radiation‐induced heart disease (RIHD), including cardiomyopathy, myocardial fibrosis, pericardial effusions, and pericarditis, occurs in adjuvant radiotherapy for breast cancer, lung cancer, and Hodgkin's lymphoma . IR could attack cardiomyocytes in the adventitia and the middle layer of the heart, resulting in cardiodysfunction even cell death.…”